Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. — VialBase Research

Summary

This is an in-vitro cell-line study, not a clinical or animal one. It evaluated five Khavinson peptides — the Epitalon tetrapeptide, the Vilon dipeptide, the Thymogen dipeptide, the Thymalin peptide complex, and the Chonluten tripeptide — as regulators of inflammatory and proliferative processes in THP-1 cells, a human leukemia monocytic line capable of differentiating into macrophages when treated with PMA in vitro. The authors note that these peptides, characterised by Prof. Khavinson from 1973 onwards, were initially isolated from animal tissues and found to be organ specific. Cultures were incubated with each peptide at concentrations already known to be effective on recipient cells in culture. All five peptides were found to modulate key proliferative patterns by increasing tyrosine phosphorylation of mitogen-activated cytoplasmic kinases. On the inflammatory side, the Chonluten tripeptide — derived from bronchial epithelial cells — inhibited TNF production in monocytes exposed to pro-inflammatory bacterial lipopolysaccharide, which the authors link to the documented mechanism of TNF tolerance and attenuated inflammatory action; all five peptides, Thymalin included, inhibited LPS-stimulated expression of TNF and pro-inflammatory IL-6 in terminally differentiated THP-1 cells. In a final assay, peptide-treated THP-1 cells incubated on a layer of LPS-activated HUVEC endothelial cells showed reduced adhesion, a typical pro-inflammatory mechanism. The authors conclude that the Khavinson peptides cooperate as natural inducers of TNF tolerance in monocytes and act on macrophages as anti-inflammatory molecules during inflammatory and microbial-mediated activity.

Key Findings

• Entirely in vitro: the model was the human THP-1 monocytic leukemia cell line differentiated into macrophages by PMA, with a secondary adhesion assay on LPS-activated HUVEC endothelial cells
• Thymalin was tested as one of five Khavinson peptides (Epitalon, Vilon, Thymogen, Thymalin, Chonluten), so the findings are class-level rather than Thymalin-specific
• All five peptides increased tyrosine phosphorylation of mitogen-activated cytoplasmic kinases, modulating key proliferative patterns
• All five peptides inhibited LPS-stimulated TNF and IL-6 expression in terminally differentiated THP-1 cells; Chonluten specifically inhibited TNF production in LPS-exposed monocytes, which the authors tie to TNF tolerance
• Peptide-treated THP-1 cells showed reduced adhesion to activated endothelium, interpreted as attenuation of a pro-inflammatory mechanism

Relevance to Thymalin

This paper is often invoked as evidence that Thymalin is anti-inflammatory, and the honest reading is narrower than that. It is a cell-line experiment in THP-1 monocytes — an immortalised human leukemia line — with no animal or human dosing, no pharmacokinetics, and no clinical endpoint. What it demonstrates is that Thymalin, in company with four other Khavinson peptides, suppresses LPS-driven TNF and IL-6 expression and reduces monocyte adhesion to activated endothelium in culture. That is a coherent class-level signal and it is mechanistically consistent with the cytokine findings reported elsewhere in the Thymalin literature. Its distinguishing value is provenance: the author list is substantially Italian (Chieti/Ancona groups) with Khavinson as a collaborator rather than the sole originating institute, which makes it one of the few Thymalin-adjacent datasets not produced entirely in-house at the St. Petersburg Institute of Bioregulation and Gerontology. Even so, in-vitro anti-inflammatory activity is a routine finding for many peptides and does not translate automatically into immune benefit at any dose a consumer would take.

Citation

Avolio F, Martinotti S, Khavinson VK, et al. Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. International journal of molecular sciences. 2022;23(7). doi:10.3390/ijms23073607.

See Also

• Parent compound: Thymalin